California judge tosses 417 million dollars talc cancer verdict against Johnson and Johnson Ruby Khatun Khatun22 Oct 2017 10:01 AM ISTA California judge on Friday threw out a $417 million verdict against Johnson and Johnson in a lawsuit by a woman who claimed she developed ovarian...
US firms approach USTR against Indias medical price control measures Ruby Khatun Khatun22 Oct 2017 9:58 AM ISTWashington: American companies producing medical devices and health information systems have approached the US Trade Representative against India's...
GlaxoSmithKline adult shingles vaccine wins US approval Ruby Khatun Khatun22 Oct 2017 9:31 AM ISTThe U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected...
Imprimis Pharma to take on Allergans Restasis with cheaper product Ruby Khatun Khatun22 Oct 2017 9:02 AM ISTShares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to...
Gilead cancer immunotherapy wins US approval with 373,000 dollars price Ruby Khatun Khatun21 Oct 2017 10:59 AM ISTA new therapy for a type of lymphoma developed by Kite Pharma, which was acquired by Gilead Sciences Inc, won U.S. approval on Wednesday, marking the...
Abbotts recent deals, medical device pipeline to fuel growth Ruby Khatun Khatun21 Oct 2017 10:11 AM ISTAbbott Laboratories quarterly results beat estimates and the company raised the top end of its full-year earnings forecast range on Wednesday, as a...
Doctor Insta to raise 4 million dollars for expansion Ruby Khatun Khatun21 Oct 2017 9:42 AM ISTAhmedabad: A video medicine platform Doctor Insta backed by RoundGlass Partners and BrahmaX Ventures is looking to raise 4 million dollars of funding...
Trump promises action on drug prices that may impact India Ruby Khatun Khatun21 Oct 2017 9:30 AM ISTWashington: US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Novartis Revolade shows long-term disease control for chronic/persistent immune thrombocytopenia Ruby Khatun Khatun21 Oct 2017 9:09 AM ISTZURICH: Novartis said on Wednesday a long-term study of its Revolade drug showed good results in treating chronic and persistent immune...
VPS Healthcare sets aside Rs 1,000 crore for investing in Indian Hospital Space Ruby Khatun Khatun20 Oct 2017 10:35 AM ISTMUMBAI: The son-in-law of the Lulu Group founder MA Yusuf Ali and founder of VPS Healthcare Group, Dr Shamsheer Vayalil, is reported to have created a...
Granules US partner gets ANDA approval for Prasugrel tablets Ruby Khatun Khatun20 Oct 2017 10:25 AM ISTNew Delhi: Drug firm Granules India said US pharma Windlas LLC has received approval from the US health regulator for generic Prasugrel tablets used...
